Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Champiat, Stephane ^a   Raposo, Rui André Saraiva ^a   Maness, Nicholas J ^b   Lehman, John L ^a,f   Purtell, Sean E ^f   Hasenkrug, Aaron M ^a   Miller, Jacob C ^a   Dean, Hansi ^c   Koff, Wayne C ^c   Hong, Marisa Ailin ^d,g   Martin, Jeffrey N ^e   Deeks, Steven G ^a   Spotts, Gerald E ^a   Pilcher, Christopher D ^a   Hecht, Fredrick M ^a   Kallas, Esper G ^d   Garrison, Keith E ^f   Nixon, Douglas F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c INTERNATIONAL AIDS VACCINE INITIATIVE   (United States)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f SAINT MARY'S COLLEGE OF CALIFORNIA   (United States)

^g INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EPITOPE; NUCLEOTIDE; VIRUS ENVELOPE PROTEIN;

ACUTE DISEASE; ALTERNATIVE READING FRAME; ARTICLE; CELLULAR IMMUNITY; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNE RESPONSE; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; VIRUS TRANSCRIPTION;

ACUTE DISEASE; ADULT; AMINO ACID SEQUENCE; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BASE SEQUENCE; CHRONIC DISEASE; DISEASE PROGRESSION; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENOME, VIRAL; GEOGRAPHY; HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; NUCLEOTIDES; PEPTIDES; READING FRAMES; RECOMBINATION, GENETIC; SEQUENCE DELETION; T-LYMPHOCYTES;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84863093421     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039311     Document Type: Article

References (51)

1. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB, (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68: 6103-6110.
2. Friedrich TC, Valentine LE, Yant LJ, Rakasz EG, Piaskowski SM, et al. (2007) Subdominant CD8+ T-cell responses are involved in durable control of AIDS virus replication. J Virol 81: 3465-3476.
3. Jin X, Bauer DE, Tuttleton SE, Lewin S, Gettie A, et al. (1999) Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques. J Exp Med 189: 991-998.
4. Schmitz JE, Kuroda MJ, Santra S, Sasseville VG, Simon MA, et al. (1999) Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. Science 283: 857-860.
5. Liu J, O'Brien KL, Lynch DM, Simmons NL, La Porte A, et al. (2009) Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91.
6. McElrath MJ, De Rosa SC, Moodie Z, Dubey S, Kierstead L, et al. (2008) HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
7. Addo MM, Altfeld M, Rosenberg ES, Eldridge RL, Philips MN, et al. (2001) The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc Natl Acad Sci U S A 98: 1781-1786.
8. Addo MM, Yu XG, Rathod A, Cohen D, Eldridge RL, et al. (2003) Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J Virol 77: 2081-2092.
9. Altfeld M, Addo MM, Eldridge RL, Yu XG, Thomas S, et al. (2001) Vpr is preferentially targeted by CTL during HIV-1 infection. J Immunol 167: 2743-2752.
10. Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, et al. (2001) Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 75: 11983-11991.
11. Novitsky V, Cao H, Rybak N, Gilbert P, McLane MF, et al. (2002) Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J Virol 76: 10155-10168.
12. Yu XG, Addo MM, Rosenberg ES, Rodriguez WR, Lee PK, et al. (2002) Consistent patterns in the development and immunodominance of human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T-cell responses following acute HIV-1 infection. J Virol 76: 8690-8701.
13. Bullock TN, Eisenlohr LC, (1996) Ribosomal scanning past the primary initiation codon as a mechanism for expression of CTL epitopes encoded in alternative reading frames. J Exp Med 184: 1319-1329.
14. Fetten JV, Roy N, Gilboa E, (1991) A frameshift mutation at the NH2 terminus of the nucleoprotein gene does not affect generation of cytotoxic T lymphocyte epitopes. J Immunol 147: 2697-2705.
15. Probst-Kepper M, Stroobant V, Kridel R, Gaugler B, Landry C, et al. (2001) An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J Exp Med 193: 1189-1198.
16. Rimoldi D, Rubio-Godoy V, Dutoit V, Lienard D, Salvi S, et al. (2000) Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma. J Immunol 165: 7253-7261.
17. Saeterdal I, Bjorheim J, Lislerud K, Gjertsen MK, Bukholm IK, et al. (2001) Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer. Proc Natl Acad Sci U S A 98: 13255-13260.
18. Wang RF, Parkhurst MR, Kawakami Y, Robbins PF, Rosenberg SA, (1996) Utilization of an alternative open reading frame of a normal gene in generating a novel human cancer antigen. J Exp Med 183: 1131-1140.
19. Saulquin X, Scotet E, Trautmann L, Peyrat MA, Halary F, et al. (2002) +1 Frameshifting as a novel mechanism to generate a cryptic cytotoxic T lymphocyte epitope derived from human interleukin 10. J Exp Med 195: 353-358.
20. Mayrand SM, Green WR, (1998) Non-traditionally derived CTL epitopes: exceptions that prove the rules? Immunol Today 19: 551-556.
21. Weiss RB, Dunn DM, Atkins JF, Gesteland RF, (1987) Slippery runs, shifty stops, backward steps, and forward hops:-2,-1, +1, +2, +5, and +6 ribosomal frameshifting. Cold Spring Harb Symp Quant Biol 52: 687-693.
22. McBratney S, Chen CY, Sarnow P, (1993) Internal initiation of translation. Curr Opin Cell Biol 5: 961-965.
23. Bullock TN, Patterson AE, Franlin LL, Notidis E, Eisenlohr LC, (1997) Initiation codon scanthrough versus termination codon readthrough demonstrates strong potential for major histocompatibility complex class I-restricted cryptic epitope expression. J Exp Med 186: 1051-1058.
24. Bruce AG, Atkins JF, Gesteland RF, (1986) tRNA anticodon replacement experiments show that ribosomal frameshifting can be caused by doublet decoding. Proc Natl Acad Sci U S A 83: 5062-5066.
25. Malarkannan S, Horng T, Shih PP, Schwab S, Shastri N, (1999) Presentation of out-of-frame peptide/MHC class I complexes by a novel translation initiation mechanism. Immunity 10: 681-690.
26. Bansal A, Carlson J, Yan J, Akinsiku OT, Schaefer M, et al. (2010) CD8 T cell response and evolutionary pressure to HIV-1 cryptic epitopes derived from antisense transcription. J Exp Med 207: 51-59.
27. Berger CT, Carlson JM, Brumme CJ, Hartman KL, Brumme ZL, et al. (2010) Viral adaptation to immune selection pressure by HLA class I-restricted CTL responses targeting epitopes in HIV frameshift sequences. J Exp Med 207: 61-75.
28. Cardinaud S, Moris A, Fevrier M, Rohrlich PS, Weiss L, et al. (2004) Identification of cryptic MHC I-restricted epitopes encoded by HIV-1 alternative reading frames. J Exp Med 199: 1053-1063.
29. Maness NJ, Sacha JB, Piaskowski SM, Weisgrau KL, Rakasz EG, et al. (2009) Novel translation products from simian immunodeficiency virus SIVmac239 Env-encoding mRNA contain both Rev and cryptic T-cell epitopes. J Virol 83: 10280-10285.
30. Maness NJ, Valentine LE, May GE, Reed J, Piaskowski SM, et al. (2007) AIDS virus specific CD8+ T lymphocytes against an immunodominant cryptic epitope select for viral escape. J Exp Med 204: 2505-2512.
31. Maness NJ, Wilson NA, Reed JS, Piaskowski SM, Sacha JB, et al. (2010) Robust, vaccine-induced CD8(+) T lymphocyte response against an out-of-frame epitope. J Immunol 184: 67-72.
32. Garrison KE, Champiat S, York VA, Agrawal AT, Kallas EG, et al. (2009) Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol 16: 1369-1371.
33. Landry S, Halin M, Lefort S, Audet B, Vaquero C, et al. (2007) Detection, characterization and regulation of antisense transcripts in HIV-1. Retrovirology 4: 71.
34. Ludwig LB, Ambrus JL Jr, Krawczyk KA, Sharma S, Brooks S, et al. (2006) Human Immunodeficiency Virus-Type 1 LTR DNA contains an intrinsic gene producing antisense RNA and protein products. Retrovirology 3: 80.
35. Michael NL, Vahey MT, d'Arcy L, Ehrenberg PK, Mosca JD, et al. (1994) Negative-strand RNA transcripts are produced in human immunodeficiency virus type 1-infected cells and patients by a novel promoter downregulated by Tat. J Virol 68: 979-987.
36. Ho O, Green WR, (2006) Cytolytic CD8+ T cells directed against a cryptic epitope derived from a retroviral alternative reading frame confer disease protection. J Immunol 176: 2470-2475.
37. Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, et al. (2004) Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol 78: 3233-3243.
38. Meiklejohn DA, Karlsson RK, Karlsson AC, Chapman JM, Nixon DF, et al. (2004) ELISPOT cell rescue. J Immunol Methods 288: 135-147.
39. Schwab SR, Shugart JA, Horng T, Malarkannan S, Shastri N, (2004) Unanticipated antigens: translation initiation at CUG with leucine. PLoS Biol 2: e366.
40. Schmitt M, Harrer E, Goldwich A, Bauerle M, Graedner I, et al. (2000) Specific recognition of lamivudine-resistant HIV-1 by cytotoxic T lymphocytes. AIDS 14: 653-658.
41. Samri A, Haas G, Duntze J, Bouley JM, Calvez V, et al. (2000) Immunogenicity of mutations induced by nucleoside reverse transcriptase inhibitors for human immunodeficiency virus type 1-specific cytotoxic T cells. J Virol 74: 9306-9312.
42. Mueller SM, Schaetz B, Eismann K, Bergmann S, Bauerle M, et al. (2007) Dual selection pressure by drugs and HLA class I-restricted immune responses on human immunodeficiency virus type 1 protease. J Virol 81: 2887-2898.
43. Mason RD, Bowmer MI, Howley CM, Gallant M, Myers JC, et al. (2004) Antiretroviral drug resistance mutations sustain or enhance CTL recognition of common HIV-1 Pol epitopes. J Immunol 172: 7212-7219.
44. Manosuthi W, Butler DM, Perez-Santiago J, Poon AF, Pillai SK,et al. Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure. AIDS 24: 411-416.
45. Mahnke L, Clifford D, (2006) Cytotoxic T cell recognition of an HIV-1 reverse transcriptase variant peptide incorporating the K103N drug resistance mutation. AIDS Res Ther 3: 21.
46. Karlsson AC, Deeks SG, Barbour JD, Heiken BD, Younger SR, et al. (2003) Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease gene. J Virol 77: 6743-6752.
47. John M, Moore CB, James IR, Mallal SA, (2005) Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1. Antivir Ther 10: 551-555.
48. Gatanaga H, Ode H, Hachiya A, Hayashida T, Sato H, et al. (2010) Impact of human leukocyte antigen-B*51-restricted cytotoxic T-lymphocyte pressure on mutation patterns of nonnucleoside reverse transcriptase inhibitor resistance. AIDS 24: F15-22.
49. Mueller SM, Spriewald BM, Bergmann S, Eismann K, Leykauf M, et al. (2011) Influence of major HIV-1 protease inhibitor resistance mutations on CTL recognition. J Acquir Immune Defic Syndr 56: 109-117.
50. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, et al. (2007) CD8+ T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 13: 46-53.
51. Goepfert PA, Lumm W, Farmer P, Matthews P, Prendergast A, et al. (2008) Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients. J Exp Med 205: 1009-1017.